申请人:R.J. REYNOLDS TOBACCO COMPANY
公开号:EP0559495A1
公开(公告)日:1993-09-08
The use in the treatment of neurodegenerative disease is described of a substituted nicotine compound having the formula (1):
where R represents H or alkyl, R¹ represents alkyl, X represents halo or alkyl, n represents an integer from 0-4 and m represents an integar from 0-3, provided that n plus m equals at least 1.
Exemplary nicotine compounds are 5-fluoronicotine, 5-bromonicotine, 4¹-methylnicotine and 5-methylnicotine.
描述了具有式(1)的取代尼古丁化合物在治疗神经退行性疾病中的用途:
其中 R 代表 H 或烷基,R¹ 代表烷基,X 代表卤代或烷基,n 代表 0-4 的整数,m 代表 0-3 的整数,条件是 n 加 m 至少等于 1。
典型的尼古丁化合物有 5-氟烟碱、5-溴烟碱、4¹-甲基尼古丁和 5-甲基尼古丁。